Yahoo Web Search

  1. Ads
    related to ELI LILLY AND COMPANY
  1. J&J's Invokana sNDA Gets Priority Review Status From FDA

    Zacks via Yahoo FinanceMay 23 12:20 PM

    Johnson & Johnson JNJ announced that the FDA has granted priority review to a supplemental new drug application (sNDA) looking for label expansion of its type II diabetes medicine, Invokana.

  2. WDAY and Palo Alto Networks, Inc. PANW. Noodles & Company went public in June of 2013 and has had a rough ride. Sell-side analysts took this queue and raised their ...

  3. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ServiceNow ...

  4. Inheris Biopharma will be led by Jay Galeota, who has been appointed as the president and chief executive officer of the entity. He held several leadership positions at Merck MRK in the ...

  5. “Requiring the inclusion of drugs’ list prices in TV ads is the single most significant step any administration has taken toward a simple commitment: American patients deserve to know the prices ...

  6. 3 Tech Stocks for Growth Investors to Buy Right Now

    Zacks via Yahoo FinanceMay 22 20:30 PM

    Growth investors are often focused on finding companies whose earnings and revenue are expected to outpace the market. This investment strategy comes with its share of risks. Yet, it also brings the exciting possibility of outsized returns.

  7. What Is Nektar Therapeutics' New Game Plan?

    Motley Fool via Yahoo FinanceMay 25 14:19 PM

    More recently, Nektar shifted gears and decided to spin off its potential new painkiller into a separate company and investors want to know why. Ionis' first drug to earn ...

  8. In other news, AbbVie's ABBV late-stage study on a brain cancer candidate failed while Lilly's LLY Crohn's disease candidate succeeded in a mid-stage study. Recap of the Week's Most Important ...

  9. Colorado insulin price cap: A look at how much prices have increased

    Fox Business via Yahoo FinanceMay 26 17:48 PM

    The cost of insulin, used to regulate blood sugar levels for people with diabetes, could cost about $600 to $900 for many people and up to $1,000 for those with health care that requires ...

  10. Here's Why Array BioPharma Is Surging Today

    Motley Fool via Yahoo FinanceMay 21 16:42 PM

    Over the same time frame, Array received $101 million in collaboration and license revenue from Novartis (NYSE: NVS) and Loxo Oncology, which is now an Eli Lilly ...

  1. Ads
    related to ELI LILLY AND COMPANY